comparemela.com
Home
Live Updates
Gabather Ab - Breaking News
Pages:
Gabather Ab News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
/PRNewswire/ Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for.
Michael robin witt
Psychiatric centre in glostrup
Innovation fund denmark
Centre for neuropsychiatric schizophrenia research
Nasdaq first north growth market
Collaborative agreement
Neuropsychiatric schizophrenia research
Psychiatric centre
Investment agreement
Positive allosteric modulator
Robin witt
First north growth market
Corpura fondkommission
Gabather ab
Health care amp hospitals
Medical pharmaceuticals
vimarsana © 2020. All Rights Reserved.